Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis

ClinicalTrials.gov ID: NCT01243983

Public ClinicalTrials.gov record NCT01243983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Masked, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Voclosporin as Therapy in Subjects With Active Noninfectious Uveitis Involving the Intermediate and/or Posterior Segments of the Eye

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to assess the safety and efficacy of voclosporin as therapy in subjects with active noninfectious uveitis involving the intermediate and/or posterior segments of the eye (i.e., anterior + intermediate-, intermediate-, posterior- or pan-uveitis).

Study identification

NCT ID
NCT01243983
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lux Biosciences, Inc.
Industry
Enrollment
155 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2011 (Type not available)
Primary completion
Dec 2012 (Actual)
Completion
Dec 2012 (Actual)
Last update posted
Jan 10, 2013

2011 – 2012

United States locations

U.S. sites
28
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Not listed Peoria Arizona 85381 —
Not listed Phoenix Arizona 85014 —
Not listed Little Rock Arkansas 72205 —
Not listed Beverly Hills California 90211 —
Not listed Mountain View California 94040 —
Not listed Sacramento California 95819 —
Not listed Santa Ana California 92705 —
Not listed Torrance California 90503 —
Not listed Indianapolis Indiana 46290 —
Not listed Ellsworth Maine 04605 —
Not listed Baltimore Maryland 21287 —
Not listed Cambridge Massachusetts 02142 —
Not listed Newark New Jersey 07103 —
Not listed Belmont North Carolina 28012 —
Not listed Winston-Salem North Carolina 27157 —
Not listed Cleveland Ohio 44122 —
Not listed Cleveland Ohio 44195 —
Not listed Dublin Ohio 43016 —
Not listed Middleburg Heights Ohio 44130 —
Not listed Ashland Oregon 97520 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Ladson South Carolina 29456 —
Not listed Arlington Texas 76012 —
Not listed Dallas Texas 75231 —
Not listed Houston Texas 77030 —
Not listed San Antonio Texas 78240 —
Not listed Norfolk Virginia 23502 —
Not listed Richmond Virginia 23219 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01243983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2013 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01243983 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →